Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Axillary metastases in breast cancer patients with negative sentinel nodes: a follow-up of 3548 cases.

Veronesi U, Galimberti V, Paganelli G, Maisonneuve P, Viale G, Orecchia R, Luini A, Intra M, Veronesi P, Caldarella P, Renne G, Rotmensz N, Sangalli C, De Brito Lima L, Tullii M, Zurrida S.

Eur J Cancer. 2009 May;45(8):1381-8. doi: 10.1016/j.ejca.2008.11.041. Epub 2009 Jan 6.

PMID:
19128957
3.

Avoiding axillary treatment in sentinel lymph node micrometastases of breast cancer: a prospective analysis of axillary or distant recurrence.

Pernas S, Gil M, Benítez A, Bajen MT, Climent F, Pla MJ, Benito E, Guma A, Gutierrez C, Pisa A, Urruticoechea A, Pérez J, Gil Gil M.

Ann Surg Oncol. 2010 Mar;17(3):772-7.

PMID:
20183912
4.

Erratum to: Axillary recurrence rate following negative sentinel node biopsy for invasive breast cancer: long-term follow-up.

Kiluk JV, Ly QP, Santillan AA, Meade T, Ramos D, Reintgen DS, Dessureault S, Davis M, Shamehdi C, Cox CE.

Ann Surg Oncol. 2010 Feb;17(2):552-7. doi: 10.1245/s10434-009-0800-2.

PMID:
19957043
5.

Sentinel lymph node biopsy performed after neoadjuvant chemotherapy is accurate in patients with documented node-positive breast cancer at presentation.

Newman EA, Sabel MS, Nees AV, Schott A, Diehl KM, Cimmino VM, Chang AE, Kleer C, Hayes DF, Newman LA.

Ann Surg Oncol. 2007 Oct;14(10):2946-52. Epub 2007 May 19.

PMID:
17514407
6.

Omitting axillary lymph node dissection in sentinel node negative breast cancer patients is safe: a long term follow-up analysis.

Torrenga H, Fabry H, van der Sijp JR, van Diest PJ, Pijpers R, Meijer S.

J Surg Oncol. 2004 Oct 1;88(1):4-7; discussion 7-8.

PMID:
15384064
7.

Sentinel node biopsy in breast cancer: early results in 953 patients with negative sentinel node biopsy and no axillary dissection.

Veronesi U, Galimberti V, Mariani L, Gatti G, Paganelli G, Viale G, Zurrida S, Veronesi P, Intra M, Gennari R, Rita Vento A, Luini A, Tullii M, Bassani G, Rotmensz N.

Eur J Cancer. 2005 Jan;41(2):231-7.

PMID:
15661547
8.

Survival after negative sentinel lymph node biopsy in breast cancer at least equivalent to after negative extensive axillary dissection.

Kuijt GP, van de Poll-Franse LV, Voogd AC, Nieuwenhuijzen GA, Roumen RM.

Eur J Surg Oncol. 2007 Sep;33(7):832-7. Epub 2006 Dec 29.

PMID:
17197151
10.

Treatment of 100 patients with sentinel node-negative breast cancer without further axillary dissection.

Roumen RM, Kuijt GP, Liem IH, van Beek MW.

Br J Surg. 2001 Dec;88(12):1639-43.

PMID:
11736979
11.

Axillary lymph node dissection can be avoided in women with breast cancer with intraoperative, false-negative sentinel lymph node biopsies.

Takei H, Kurosumi M, Yoshida T, Ishikawa Y, Hayashi Y, Ninomiya J, Tozuka K, Oba H, Inoue K, Nagai S, Saito Y, Kazumoto T, Saitoh J, Tabei T.

Breast Cancer. 2010;17(1):9-16. doi: 10.1007/s12282-009-0154-4. Epub 2009 Aug 22.

PMID:
19701679
12.

Study finds omission of axillary lymph node dissection safe for patients with sentinel node micrometastases.

Dreyfuss JH.

CA Cancer J Clin. 2010 Jan-Feb;60(1):2-3. doi: 10.3322/caac.20053. Epub 2009 Dec 16. No abstract available.

13.

Internal mammary node irradiation neither decreases distant metastases nor improves survival in stage I and II breast cancer.

Fowble B, Hanlon A, Freedman G, Nicolaou N, Hoffman J, Sigurdson E, Boraas M, Torosian M, Goldstein L.

Int J Radiat Oncol Biol Phys. 2000 Jul 1;47(4):883-94.

PMID:
10863056
14.

Low locoregional failure rates in selected breast cancer patients with tumor-positive sentinel lymph nodes who do not undergo completion axillary dissection.

Hwang RF, Gonzalez-Angulo AM, Yi M, Buchholz TA, Meric-Bernstam F, Kuerer HM, Babiera GV, Tereffe W, Liu DD, Hunt KK.

Cancer. 2007 Aug 15;110(4):723-30.

15.

Patients with breast cancer and negative sentinel lymph node biopsy without additional axillary lymph node dissection: a follow-up study of up to 5 years.

Domènech A, Benitez A, Bajén MT, Pla MJ, Gil M, Martín-Comín J.

Oncology. 2007;72(1-2):27-32. Epub 2007 Nov 12.

PMID:
17998787
17.

Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.

Kim KJ, Huh SJ, Yang JH, Park W, Nam SJ, Kim JH, Lee JH, Kang SS, Lee JE, Kang MK, Park YJ, Nam HR.

Jpn J Clin Oncol. 2005 Mar;35(3):126-33.

PMID:
15741302
18.

Axillary lymph node dissection for sentinel lymph node micrometastases may be safely omitted in early-stage breast cancer patients: long-term outcomes of a prospective study.

Langer I, Guller U, Viehl CT, Moch H, Wight E, Harder F, Oertli D, Zuber M.

Ann Surg Oncol. 2009 Dec;16(12):3366-74. doi: 10.1245/s10434-009-0660-9. Epub 2009 Sep 4.

PMID:
19760047
19.

Is axillary lymph node dissection necessary in elderly patients with breast carcinoma who have a clinically uninvolved axilla?

Martelli G, Miceli R, De Palo G, Coradini D, Salvadori B, Zucali R, Galante E, Marubini E.

Cancer. 2003 Mar 1;97(5):1156-63.

20.

The incidence and significance of micrometastases in lymph nodes of patients with ductal carcinoma in situ and T1a carcinoma of the breast.

Broekhuizen LN, Wijsman JH, Peterse JL, Rutgers EJ.

Eur J Surg Oncol. 2006 Jun;32(5):502-6. Epub 2006 Mar 29.

PMID:
16569492

Supplemental Content

Support Center